Dose Response to Recombinant Factor VIIa When Administered for Bleed

NCT00104455 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Healthy

Interventions

DRUG: activated recombinant human factor VII

Sponsor

Novo Nordisk A/S